The evolving epidemiology of hepatocellular carcinoma: a global perspective

被引:368
作者
Wallace, Michael C. [1 ,2 ,3 ]
Preen, David [2 ]
Jeffrey, Gary P. [1 ,3 ]
Adams, Leon A. [1 ,3 ]
机构
[1] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia
[2] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia
[3] Sir Charles Gairdner Hosp, Liver Transplant Unit, Perth, WA, Australia
关键词
chronic viral hepatitis; cirrhosis; epidemiology; hepatocellular carcinoma; nonalcoholic fatty liver disease; HEPATITIS-B-VIRUS; PRIMARY LIVER-CANCER; SUSTAINED VIROLOGICAL RESPONSE; NUCLEOS(T)IDE ANALOG THERAPY; HIV-INFECTED PATIENTS; RISK-FACTORS; VIRAL-HEPATITIS; UNITED-STATES; REDUCED RISK; LONG-TERM;
D O I
10.1586/17474124.2015.1028363
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary liver cancer, the majority of which are hepatocellular carcinomas, is now the second leading cause of cancer death worldwide. Hepatocellular carcinoma is a unique cancer that typically arises in the setting of chronic liver disease at a rate dependent upon the complex interplay between the host, disease and environmental factors. Infection with chronic hepatitis B or C virus is currently the dominant risk factor worldwide. However, changing lifestyle and environmental factors in western countries plus rising neonatal hepatitis B vaccination rates and decreasing exposure to dietary aflatoxins in developing countries are driving an evolution of the epidemiology of this cancer. An understanding of this change is crucial in combating the rising incidence currently being seen in western regions and will underpin the efforts to reduce the mortality rates associated with this cancer.
引用
收藏
页码:765 / 779
页数:15
相关论文
共 138 条
[1]   Nonalcoholic fatty liver disease [J].
Adams, Leon A. ;
Lindor, Keith D. .
ANNALS OF EPIDEMIOLOGY, 2007, 17 (11) :863-869
[2]   A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C-Associated Liver Cirrhosis [J].
Aleman, Soo ;
Rahbin, Nogol ;
Weiland, Ola ;
Davidsdottir, Loa ;
Hedenstierna, Magnus ;
Rose, Nina ;
Verbaan, Hans ;
Stal, Per ;
Carlsson, Tony ;
Norrgren, Hans ;
Ekbom, Anders ;
Granath, Fredrik ;
Hultcrantz, Rolf .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (02) :230-236
[3]   Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: A clinical and pathological study [J].
Alexander, Jacob ;
Torbenson, Michael ;
Wu, Tsung-Teh ;
Yeh, Matthew M. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (05) :848-854
[4]   Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States [J].
Altekruse, Sean F. ;
Henley, S. Jane ;
Cucinelli, James E. ;
McGlynn, Katherine A. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (04) :542-553
[5]   Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 [J].
Altekruse, Sean F. ;
McGlynn, Katherine A. ;
Reichman, Marsha E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1485-1491
[6]   Hepatocellular carcinoma in patients with acute hepatic porphyria:: frequency of occurrence and related factors [J].
Andant, C ;
Puy, H ;
Bogard, C ;
Faivre, J ;
Soulé, JC ;
Nordmann, Y ;
Deybach, JC .
JOURNAL OF HEPATOLOGY, 2000, 32 (06) :933-939
[7]  
[Anonymous], 2004, IARC MONOGRAPHS EVAL
[8]  
[Anonymous], 2014, NEW J SCI, DOI DOI 10.1155/2014/756240
[9]  
[Anonymous], 2023, Hepatitis B
[10]  
[Anonymous], 2013, GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base